Skip to main content
OpenTrials

Clinical trial condition

Systemic Scleroderma

Explore clinical trials studying Systemic Scleroderma. Study availability and eligibility vary by location and protocol.

26 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Systemic Scleroderma trial results

Recruiting

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

NCT03816345

Conditions
Arthritis, Arthritis, Psoriatic, Arthritis, Rheumatoid, +59 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
View all 52 locations
View Trial Details
Recruiting

Familial Systemic Scleroderma

NCT07343115

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +4 more
Locations
  • Service de Médecine interne et Immunologie clinique - CHU de Strasbourg - France Strasbourg, France
View Trial Details
Not yet recruiting

Efficacy and Safety of Allogenic Cultured Adipose-derived Mesenchymal Stromal Cell Injections on MoUth Fibrosis and Handicap in Patients With Systemic sclEroderma

NCT07326033

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +9 more
Locations
  • Bordeaux Hospital Bordeaux, France
  • Dijon Hospital Dijon, France
  • Montpellier Hospital Montpellier, France
  • Nantes Hospital Nantes, France
View Trial Details

Related conditions